Professional Documents
Culture Documents
AAN PERAWATAN
LUKA
KANKER
Tujuan Pembelajaran
http://healthncare.info/wp-content/uploads/2014/07/Skin-Cancer-Sign-and-Symptoms.png
PATHOPHYSIOLOG
Y
Cancer has a complex Pathophysiology. Pathologists are physicians who are concerned primarily with the study of disease in all
its aspects. This includes cause of the disease, diagnosis, how the disease develops (pathogenesis), mechanism and natural
course of the disease. They also deal with biochemical features, progression, and prognosis or outcome of the disease.
Tumor suppressor genes – these genes normally inhibit cell division and prevent survival of cells that have damaged DNA. In
patients with cancer these tumor suppressor genes are often disabled. This is caused by cancer-promoting genetic changes.
Typically, changes in many genes are required to transform a normal cell into a cancer cell.
MEDICAL INTERVENTION
• Operative (SIDE EFFECT: surgical break down
– dehisence )
• Radiation (SIDE EFFECT: desquamation)
• Chemotherapy (SIDE EFFECT: extravasation)
• Hormonal therapy
• Antibiotic for infection
• Pain control
LUKA
KANKER
fungating malignant wound
malignant cutaneous wound.
Creative dressing techniques can help restore the look of symmetry to the patient's body. Effective
wound management, debridement, and antimicrobial therapy can reduce the risk of infection. Wound cleansing,
through irrigation or flushing, should not cause pain, further trauma or bleeding. Dressings should maintain a
moist wound environment and not traumatize the wound upon removal.
A protocol is included which can be individualized to the needs of each patient and addresses assessment,
interventions, patient teaching, documentation, and expected outcomes.
Certified
Wound Care
Clinician
PERAWATAN
PALIATIF
Associate
TUJUAN :
•MENINGKATKAN RASA NYAMAN
•MEMPERTAHANKAN / MENINGKATKAN
KUALITAS HIDUP LAYAK
FOKUS PERAWATAN:
MENGONTROL / MENGHILANGKAN
GEJALA YANG DITIMBULKAN
LUKA KANKER
Certified
Wound Care
Clinician
KANKER DAN PELAYANAN
Associate
PALIATIVE
Diperkirakan sekitar 7.2 sampai
7.5 juta individu di dunia meninggal
karena kanker setiap
tahunnya.
• Pemberi pelayanan paliatif harus sensitif terhadap kebutuhan pasien, budaya, agama,
kepercayaan yang dianut, dan komunikasi dipastikan terjadi secara efektif
Certified
Wound Care
Clinician
TIM YANG
TERLIBAT
Associate
PENATALAKSANAAN:
• Meminimalisasi terjadinya perdarahan dan
trauma saat membuka balutan
• Hindari temperature yang ekstreem
• Tekan tempat perdarahan dg GENTLE
• Monitor adanya anemia dan kebutuhan
transfusi
PATIENT RESPONS :
BALUTAN CEPAT BASAH, MALU, JIJIK, RASA
BERSALAH, DEHIDRASI
PENATALAKSANAAN:
• Cuci luka dan kulit sekitar luka dengan bersih – gentle
antiseptic
• Gunakan balutan menyerap cairan yang berlebihan (high
exudate: calsium alginate, padding or gamgee)
• Lindungi kulit sekitarnya dari iritasi akibat cairan yang
meleleh dengan zinc cream
• Monitor kebutuhan cairan dan elektrolit
BAU TIDAK
SEDAP
PENYEBAB:
PATIENT RESPONS :
PENATALAKSANAAN :
• Mencuci luka dengan larutan gentle
antiseptik
•Mengontrol bau – menggunakan dressing
odor control/ Metronidazole bubuk
• Personal higine pasien
• Meningkatkan rasa percaya diri
INFEKS
I
An infection occurs when the immune
system does not quickly destroy harmful
substances. Both cancer and cancer treatments
weaken the immune system.
This means that people with
cancer are more likely to develop
infections.
PASIEN RESPON :
• Takut ganti balutan
• Mudah marah - Menangis
• Frustasi - kesakitan
PENATALAKSANAAN:
• Hati-hati saat membuka balutan
• Hindari perlakuan secara kasar
• Mencuci luka dengan lembut
• Hindari menggosok luka hingga berdarah.
• Kolaborasi obat nyeri pada dokter/ minum obat
nyeri sesaat sebelum dilakukan penggantian
balutan
MASERAS
I
Prolonged exposure to moisture may remove the protective barrier
causing more damage.
PENATALAKSANAAN:
Menurunkan segala
keluhan pasien,
masalah sosial
dan spiritual
dengan meningkatkan
atau mempertahankan
wellbeing
pasien.
• Probst S, Arber A, Faithfull S. Malignant fungating wounds: a survey of nurses' clinical practice in Switzerland. Eur J Oncol Nurs. 2009
Sep;13(4):295-8. doi: 10.1016/j.ejon.2009.03.008. Epub 2009 Apr 21. PMID: 19386546.
• Seaman S. Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs. 2006 Aug;22(3):
• 185-93. doi: 10.1016/j.soncn.2006.04.006. PMID: 16893748.
• McNees P. Skin and wound assessment and care in oncology. Semin Oncol Nurs. 2006 Aug;22(3):130-43. doi: 10.1016/j.soncn.2006.04.003.
PMID: 16893742.
• Dowsett C. Malignant fungating wounds: assessment and management. Br J Community Nurs. 2002 Aug;7(8): 394-400. doi:
10.12968/bjcn.2002.7.8.10641. PMID: 12192342.
• Grocott P. The palliative management of fungating malignant wounds. J Wound Care. 2000 Jan;9(1):4-9. doi: 10.12968/jowc.2000.9.1.25942.
PMID: 10827661.
• Bergstrom, K.Assessment and Management of FungatingWounds.Source:Journal of Wound, Ostomy and Continence Nursing. 38 (1): 31-
37, 2011 Jan/Feb
• Rupert KL, Fehl AJ. A Patient-Centered Approach for the Treatment of Fungating Breast Wounds. J Adv Pract
• Oncol. 2020 Jul;11(5):503-510. doi: 10.6004/jadpro.2020.11.5.6. Epub 2020 Jul 1. PMID: 32974074; PMCID: PMC7508249.